Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.70%479.69B | 0.03%1.95T | 2.63%488B | 21.79%1.95T | 10.94%482.45B | 24.49%507.12B | 18.74%488.56B | 35.72%475.5B | 12.84%1.6T | 12.51%434.87B |
| Cost of revenue | -1.80%429.78B | 0.16%1.75T | 2.56%437.64B | 20.18%1.74T | 10.99%433.3B | 23.19%450.79B | 15.59%431.34B | 33.30%426.72B | 14.07%1.45T | 13.10%390.39B |
| Gross profit | -0.88%49.92B | -1.07%209.21B | 3.24%50.36B | 36.95%211.47B | 10.51%49.15B | 35.97%56.33B | 49.45%57.22B | 61.36%48.78B | 2.48%154.42B | 7.61%44.47B |
| Operating expense | -7.27%31.21B | 26.18%166.81B | 26.49%33.66B | 23.85%132.2B | 83.22%46.6B | 13.79%29.21B | 3.35%29.79B | -0.80%26.61B | 18.10%106.74B | 8.21%25.43B |
| Selling and administrative expenses | -3.97%32B | 13.74%136.47B | 18.67%33.32B | 12.20%119.98B | 17.20%33.55B | 13.73%29.87B | 11.35%28.49B | 6.08%28.08B | 19.46%106.94B | 26.22%28.63B |
| -General and administrative expense | -3.97%32B | 13.74%136.47B | 18.67%33.32B | 12.20%119.98B | 17.20%33.55B | 13.73%29.87B | 11.35%28.49B | 6.08%28.08B | 19.46%106.94B | 26.22%28.63B |
| Other operating expenses | -50.30%986M | 86.46%37.96B | 87.52%1.98B | 90.64%20.36B | 373.58%15.06B | 42.98%1.72B | -44.72%2.52B | -38.84%1.06B | 91.07%10.68B | 36.73%3.18B |
| Total other operating income | 7.73%1.77B | -6.37%7.62B | -34.94%1.64B | -25.14%8.14B | -68.45%2.01B | 32.46%2.38B | -7.75%1.23B | 83.70%2.52B | 129.96%10.88B | 324.00%6.38B |
| Operating profit | 12.01%18.7B | -46.51%42.4B | -24.67%16.7B | 66.29%79.27B | -86.61%2.55B | 72.10%27.13B | 189.82%27.43B | 551.01%22.17B | -20.93%47.67B | 6.83%19.04B |
| Net non-operating interest income (expenses) | -113.58%-306M | -65.18%2.52B | -33.52%2.25B | 90.50%7.24B | 558.40%5.52B | -20.87%-3.42B | 29.91%1.75B | -23.77%3.39B | -13.10%3.8B | -62.71%839M |
| Non-operating interest income | -29.80%1.89B | -26.23%7.67B | -33.74%2.7B | 58.05%10.4B | 158.22%5.3B | -18.08%947M | 61.76%2.59B | -21.68%4.07B | 2.33%6.58B | -42.95%2.05B |
| Non-operating interest expense | 394.38%2.2B | 62.97%5.15B | -34.85%445M | 13.70%3.16B | -118.81%-228M | 9.57%4.36B | 227.03%847M | -9.30%683M | 35.13%2.78B | -9.89%1.21B |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 11.04%503M | 45.58%2.18B | 350.28%453M | 83.09%1.49B | 181.48%563M | 43.93%616M | -64.10%495M | 39.67%-181M | 708.96%816M | -82.32%-691M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -2.60%18.9B | -46.49%47.1B | -23.52%19.41B | 68.30%88.01B | -55.00%8.64B | 82.05%24.32B | 143.46%29.67B | 236.08%25.37B | -18.97%52.29B | -2.55%19.19B |
| Income tax | -35.03%5.76B | 7.12%21.29B | -19.64%8.86B | -36.83%19.88B | -172.70%-9.27B | 92.00%8.14B | 43.24%9.98B | 46.91%11.03B | 69.50%31.47B | 327.89%12.75B |
| Net income | 24.68%13.14B | -62.13%25.8B | -26.51%10.54B | 227.15%68.13B | 178.09%17.91B | 77.45%16.19B | 277.24%19.69B | 34,882.93%14.34B | -54.69%20.83B | -61.48%6.44B |
| Net income continuous operations | 24.68%13.14B | -62.13%25.8B | -26.51%10.54B | 227.14%68.13B | 178.09%17.91B | 77.43%16.19B | 277.24%19.69B | 34,052.38%14.34B | -54.69%20.83B | -61.47%6.44B |
| Noncontrolling interests | 26.84%2.34B | -5.46%9.08B | 0.33%1.84B | 56.35%9.61B | 181.92%1.5B | 27.69%3.03B | 77.93%3.25B | 29.44%1.84B | -8.34%6.15B | -72.78%531M |
| Net income attributable to the company | 24.21%10.8B | -71.43%16.72B | -30.46%8.7B | 298.67%58.52B | 177.70%16.41B | 94.89%13.16B | 384.47%16.44B | 1,007.47%12.51B | -62.61%14.68B | -59.97%5.91B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 24.21%10.8B | -71.43%16.72B | -30.46%8.7B | 298.67%58.52B | 177.70%16.41B | 94.89%13.16B | 384.47%16.44B | 1,007.47%12.51B | -62.61%14.68B | -59.97%5.91B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 24.11%60.48 | -70.29%93.65 | -27.19%48.73 | 301.13%315.17 | 183.88%89.79 | 94.88%70.45 | 384.31%88 | 1,006.91%66.93 | -62.61%78.57 | -59.99%31.63 |
| Diluted earnings per share | 24.12%60.47 | -70.29%93.63 | -27.20%48.72 | 301.12%315.12 | 183.93%89.78 | 94.85%70.44 | 384.47%87.98 | 1,006.78%66.92 | -62.61%78.56 | -59.99%31.62 |
| Dividend per share | 0 | 0.00%86 | 0 | 22.86%86 | 22.86%43 | 0 | 22.86%43 | 0 | 9.38%70 | 9.38%35 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |